1989
DOI: 10.1016/0006-2952(89)90513-3
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition by REV-5901 of leukotriene release from guinea-pig and human lung tissue in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
1

Year Published

1991
1991
2012
2012

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 34 publications
0
9
1
Order By: Relevance
“…A prediction of this hypothesis is that inhibition of 5'-lipoxygenase activity should inhibit the response to stimulation of capsaicin-sensitive nerves. Indeed, the 5'-lipoxygenase inhibitor REV 5901, which inhibits the formation of leukotrienes with a dissociation constant (Kd) of -10 tM (Kusner, Marks, Aharony & Krell, 1989), inhibited the magnitude and duration of the second phase. This interpretation should be considered with caution, however, as REV 5901 has also been shown to have some peptidoleukotriene receptor antagonist activity, albeit much less potent in this regard than the other antagonists used in the study (Van Inwegen, Khandwala, Gordon, Sonnino, Coutts & Jolly, 1987).…”
Section: Discussionmentioning
confidence: 99%
“…A prediction of this hypothesis is that inhibition of 5'-lipoxygenase activity should inhibit the response to stimulation of capsaicin-sensitive nerves. Indeed, the 5'-lipoxygenase inhibitor REV 5901, which inhibits the formation of leukotrienes with a dissociation constant (Kd) of -10 tM (Kusner, Marks, Aharony & Krell, 1989), inhibited the magnitude and duration of the second phase. This interpretation should be considered with caution, however, as REV 5901 has also been shown to have some peptidoleukotriene receptor antagonist activity, albeit much less potent in this regard than the other antagonists used in the study (Van Inwegen, Khandwala, Gordon, Sonnino, Coutts & Jolly, 1987).…”
Section: Discussionmentioning
confidence: 99%
“…(at 2000 h on Day 2 and at 0800 h and 1200 h on Day 3 [15]), or with NDGA, 10 mg/100 g BW i.p. (at 2000 h on Day 2 and at 0800 h and 1600 h on Day 3 [16,17]). …”
Section: Methodsmentioning
confidence: 97%
“…Tryptase, a neutral protease stored in the cytoplasmic granules of all human mast cells, 24,32,38 can be released from human mast cells 24,31 and is a potent mitogen for human fibroblasts. 39 The tryptase content of heart tissue from patients with DCM (32.3Ϯ5.9 g/g wet tissue) and ICM (33.7Ϯ4.3 g/g wet tissue) was higher than that of control subjects (6.9Ϯ2.1 g/g wet tissue) (PϽ.05).…”
Section: Tryptase Content In the Failing Heartmentioning
confidence: 99%